New Age Ventures
VC Fund
New York, United States
New Age Ventures is a VC fund in New York focused on Health Care and Medical. Generalist venture studio with investments in healthcare, medical devices, digital health, cleantech, consumer tech, deep tech, applied AI
- Total investments:
- 30
- Last investment:
- Lead investor:
- 13%
Last updated:
For AI agents: llms.txt
Industries New Age Ventures invests in
Stages New Age Ventures invests in
Countries New Age Ventures invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $350k–$2.6M
- Pre-Seed
- $50k–$100k
- Series A
- $7.7M–$10M
Investment Focus
Industry
- Health Care 7 (23%)
- Medical 5 (17%)
- Medical Device 4 (13%)
- Software 3 (10%)
- Biotechnology 3 (10%)
Stage
- Seed 6 (20%)
- Pre-Seed 3 (10%)
- Series A 3 (10%)
- Series B 3 (10%)
- Debt Financing 2 (7%)
Country
- United States 14 (47%)
- Canada 2 (7%)
- Israel 1 (3%)
- Norway 1 (3%)
- Switzerland 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Volker Berl
Founder, Managing Partner, and CEO
|
Founder, Managing Partner, and CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
FEMSelect
|
FEMSelect is making a lasting impact on women's health by delivering an innovative technology platform. It is the developer of EnPlace, a minimally invasive and mesh-free system for pelvic floor ligament fixation. Using EnPlace takes approximately 30 minutes. The patented delivery system enables the precise guidance, insertion, anddeployment of the anchor unit. The anchor is designed to be introduced through the vaginal wall and secured to the pelvic floor ligament to provide stabilization.FEMSelect was founded in 2012 and is headquartered in Modi’in, Israel. | Series B / May 13, 2025 | |
Opterion Health
|
Opterion Health is focused to bring innovation to dialysis care and foster home dialysis to improve the quality of life for patients as well as their loved ones and to possibly increase the survival rates of people who suffer from end-stage renal disease (ESRD). | $7.2M / Debt Financing / Sep 20, 2023 | |
Goodhood
|
FixMyCar is a mobile auto repair platform that offers car repair services to every car owner. FixMyCar provides affordable and trusted rates, convenient service locations, sends in mobile car mechanics to homes, offices, or parking lots, and has flexible hours, thereby enabling customers to book their highly-rated mobile car repair services attheir convenience. | $2.6M / Seed / Jul 12, 2023 | |
Koios Medical
|
Koios Medical develops an ultrasound image analysis platform to offer early disease detection and diagnosis. The company focuses on providing software medical device products that meet or exceed customer and regulatory requirements. | $8M / Series B / Feb 17, 2023 | |
|
Goodhood
|
FixMyCar is a mobile auto repair platform that offers car repair services to every car owner. FixMyCar provides affordable and trusted rates, convenient service locations, sends in mobile car mechanics to homes, offices, or parking lots, and has flexible hours, thereby enabling customers to book their highly-rated mobile car repair services attheir convenience. | Seed / Dec 27, 2022 | |
Tabella
|
Tabella is the private and secure social faith app for Catholics. Users can stay connected digitally to their church and faith groups while growing in the faith with the best Catholic content. Tabella is free for churches. | Seed / Dec 01, 2022 | |
Telescope Innovations
|
Telescope Innovations is a chemical technology company that develops automation platforms and scalable manufacturing processes for the pharmaceutical, chemical, and critical minerals industries. The company also offers Self-Driving Lab (SDL) technology, combining AI, robotics, and analytics to enhance chemical research. Additionally, Telescope hasdeveloped the ReCRFT™ process for producing battery-grade lithium carbonate from various sources. | $1.1M / Post-IPO Equity / Nov 10, 2022 | |
|
FEMSelect
|
FEMSelect is making a lasting impact on women's health by delivering an innovative technology platform. It is the developer of EnPlace, a minimally invasive and mesh-free system for pelvic floor ligament fixation. Using EnPlace takes approximately 30 minutes. The patented delivery system enables the precise guidance, insertion, anddeployment of the anchor unit. The anchor is designed to be introduced through the vaginal wall and secured to the pelvic floor ligament to provide stabilization.FEMSelect was founded in 2012 and is headquartered in Modi’in, Israel. | $9M / Series B / Oct 19, 2022 | |
Spruce
|
Spruce develops a platform that enables individuals to receive services in their homes through a mobile app. Its services range from full housekeeping to a quick tidy up or a dog walk for a furry friend. The company was founded in 2016 and is headquartered in Austin, Texas. | $26M / Series B / Jul 19, 2022 | |
NewIV Medical
|
NewIV Medical is a developer of an IV infusion pump product designed to provide IV therapy to improve the cost of care. | Convertible Note / Jul 01, 2022 | |
| See all 30 investments → | |||
Co-Investors
Bullish
2 deals together
Mucker Capital
2 deals together
Okapi Venture Capital
2 deals together
RAD BioMed Accelerator
2 deals together
Robin Hood Ventures
2 deals together
Triventures
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does New Age Ventures invest in?
New Age Ventures invests primarily in Health Care, Medical and Medical Device startups, most often at Seed and Pre-Seed stage. Most of the 30 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is New Age Ventures's check size?
New Age Ventures typically joins rounds of $350k–$2.6M at Seed, $50k–$100k at Pre-Seed and $7.7M–$10M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds New Age Ventures participates in.
How do I contact New Age Ventures?
Public channels for New Age Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at New Age Ventures?
The team at New Age Ventures includes Volker Berl (Founder, Managing Partner, and CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
